CA2653770A1 - Combinaison de composes chimiotherapiques pour le traitement du cancer - Google Patents

Combinaison de composes chimiotherapiques pour le traitement du cancer Download PDF

Info

Publication number
CA2653770A1
CA2653770A1 CA002653770A CA2653770A CA2653770A1 CA 2653770 A1 CA2653770 A1 CA 2653770A1 CA 002653770 A CA002653770 A CA 002653770A CA 2653770 A CA2653770 A CA 2653770A CA 2653770 A1 CA2653770 A1 CA 2653770A1
Authority
CA
Canada
Prior art keywords
group
cancer
subject
substituted
alkylating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002653770A
Other languages
English (en)
Inventor
Colin Meyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Reata Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reata Pharmaceuticals Inc filed Critical Reata Pharmaceuticals Inc
Publication of CA2653770A1 publication Critical patent/CA2653770A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002653770A 2006-06-01 2006-06-01 Combinaison de composes chimiotherapiques pour le traitement du cancer Abandoned CA2653770A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/021572 WO2007139556A1 (fr) 2006-06-01 2006-06-01 Combinaison de composés chimiothérapiques pour le traitement du cancer

Publications (1)

Publication Number Publication Date
CA2653770A1 true CA2653770A1 (fr) 2007-12-06

Family

ID=38778951

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002653770A Abandoned CA2653770A1 (fr) 2006-06-01 2006-06-01 Combinaison de composes chimiotherapiques pour le traitement du cancer

Country Status (2)

Country Link
CA (1) CA2653770A1 (fr)
WO (1) WO2007139556A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT513522A1 (de) * 2012-10-15 2014-05-15 Produkem Molekulares Design Gmbh Neue Anthracyclinderivate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE546457T1 (de) * 1999-03-19 2012-03-15 Waldemar Priebe Verfahren und zusammensetzungen zur herstellung von c-3' und c-4' -anthracyclin antibiotika
US6635677B2 (en) * 1999-08-13 2003-10-21 Case Western Reserve University Methoxyamine combinations in the treatment of cancer

Also Published As

Publication number Publication date
WO2007139556A1 (fr) 2007-12-06

Similar Documents

Publication Publication Date Title
US9907787B2 (en) Method of supplementing the diet and ameliorating oxidative stress
US6537990B1 (en) Combined preparations comprising morpholine anthracyclines and anticancer agent
ES2394264T3 (es) Meta-arsenito de sodio para uso en el tratamiento de enfermedades neoplásicas metastásicas
US20120128667A1 (en) Pentamidine combinations for treating cancer
JP2003509385A (ja) 両親媒性プロドラッグ
US6403563B1 (en) Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate
JP2010270124A (ja) 抗癌組み合わせ
KR20140024069A (ko) 암 치료용 펜타미딘 배합물
JP6229865B2 (ja) エピルビシン複合化ブロック共重合体と、抗癌剤とを含むミセル、及び当該ミセルを含む癌又は耐性癌、転移癌の治療に適用可能な医薬組成物
EP1968981B1 (fr) Azaxanthones et leurs utilisations dans le traitement de tumeurs
TW201617081A (zh) 以妥布賴森（Ｔｕｂｕｌｙｓｉｎ）結合物治療癌症之方法
KR20100137570A (ko) 약제-내성 종양에서 화학요법제 활성을 증강시키는 ｏｎ01910.ｎａ
WO2008134528A1 (fr) Compositions de conjugués d'agent anticancéreux-acide hyaluronique et procédés
US20130252904A1 (en) Compositions and methods for treating cancer
CA2653770A1 (fr) Combinaison de composes chimiotherapiques pour le traitement du cancer
WO2022108992A9 (fr) Promédicament ciblant l'antigène membranaire spécifique de la prostate (psma) pour tuer sélectivement des cellules exprimant le psma
UA69423C2 (uk) Засіб для лікування пухлини печінки шляхом введення метоксиморфолінодоксорубіцину (mmdx) через печінкову артерію (варіанти)
US20230040125A1 (en) Targeting the intrinsic apoptotic machinery in glioblastoma
EP0874630B1 (fr) Poison topo-isomerase ii et therapie associee a base de derives de bis-dioxypiperazine
US20080248134A1 (en) Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof
US20090105206A1 (en) Copper Melphalan And Copper Tegafur As Anti-Tumor Agents
EP3917499A1 (fr) Commutateur d'adhérence/adsorption sur des nanoparticules pour augmenter la capture de tumeur et retarder la clairance tumorale
CN114727967A (zh) 核酸介导的治疗剂的递送

Legal Events

Date Code Title Description
FZDE Discontinued